Review
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 7, 2014; 20(21): 6504-6514
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6504
Treatment of refractory diabetic gastroparesis: Western medicine and traditional Chinese medicine therapies
Bing Pang, Qiang Zhou, Jun-Ling Li, Lin-Hua Zhao, Xiao-Lin Tong
Bing Pang, Qiang Zhou, Xiao-Lin Tong, Department of Endocrinology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
Jun-Ling Li, Beijing University of Traditional Chinese Medicine, Beijing 100029, China
Lin-Hua Zhao, Molecular Biology Laboratory, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
Author contributions: Pang B and Tong XL proposed the manuscript topic; Pang B and Zhou Q wrote the manuscript, the two of them contributed equally to this work, are both first co-author; and Li JL, Zhao LH and Tong XL revised the manuscript.
Supported by Grant from the National Basic Research Program of China, “973” Program, No. 2010CB530600
Correspondence to: Xiao-Lin Tong, Professor, Department of Endocrinology, Guang’anmen Hospital of China Academy of Chinese Medical Sciences, Room 432, Administration Building, 5 Beixiange Street, Xuanwu District, Beijing 100053, China. xiaolintong66@sina.com
Telephone: +86-10-88001260 Fax: +86-10-63014195
Received: November 16, 2013
Revised: January 13, 2014
Accepted: February 20, 2014
Published online: June 7, 2014
Abstract

Refractory diabetic gastroparesis (DGP), a disorder that occurs in both type 1 and type 2 diabetics, is associated with severe symptoms, such as nausea and vomiting, and results in an economic burden on the health care system. In this article, the basic characteristics of refractory DGP are reviewed, followed by a discussion of therapeutic modalities, which encompasses the definitions and clinical manifestations, pathogenesis, diagnosis, and therapeutic efficacy evaluation of refractory DGP. The diagnostic standards assumed in this study are those set forth in the published literature due to the absence of recognized diagnosis criteria that have been assessed by an international organization. The therapeutic modalities for refractory DGP are as follows: drug therapy, nutritional support, gastric electrical stimulation, pyloric botulinum toxin injection, endoscopic or surgical therapy, and traditional Chinese treatment. The therapeutic modalities may be used alone or in combination. The use of traditional Chinese treatments is prevalent in China. The effectiveness of these therapies appears to be supported by preliminary evidence and clinical experience, although the mechanisms that underlie these effects will require further research. The purpose of this article is to explore the potential of combined Western and traditional Chinese medicine treatment methods for improved patient outcomes in refractory DGP.

Keywords: Refractory diabetic gastroparesis, Nutrition, Gastric electrical stimulation, Botulinum toxin, Traditional Chinese treatment, Surgery

Core tip: In this review, we summarize the latest therapeutic approaches for refractory diabetic gastroparesis (DGP), a condition that may be difficult to treat. For most patients with refractory DGP, invasive and expensive treatment options are frequently applied. They cause mental suffering and are expensive, and not all patients are likely to benefit from these therapies. Therefore, as with many chronic conditions, patients may seek complementary and alternative therapies. In clinical practice, traditional Chinese medicine (TCM) appears efficacious and offers a less invasive treatment option. Moreover, preliminary evidence in the literature has also suggested the efficacy of TCM.